Cargando…
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have empirical evidence that they cause cystic fibrosi...
Autores principales: | Sosnay, Patrick R, Siklosi, Karen R, Van Goor, Fredrick, Kaniecki, Kyle, Yu, Haihui, Sharma, Neeraj, Ramalho, Anabela S, Amaral, Margarida D, Dorfman, Ruslan, Zielenski, Julian, Masica, David L, Karchin, Rachel, Millen, Linda, Thomas, Philip J, Patrinos, George P, Corey, Mary, Lewis, Michelle H, Rommens, Johanna M, Castellani, Carlo, Penland, Christopher M, Cutting, Garry R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874936/ https://www.ncbi.nlm.nih.gov/pubmed/23974870 http://dx.doi.org/10.1038/ng.2745 |
Ejemplares similares
-
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
por: Green, Deanna M, et al.
Publicado: (2010) -
Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California
por: Salinas, Danieli B., et al.
Publicado: (2016) -
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator
por: Bartoszewski, Rafal, et al.
Publicado: (2016) -
Postzygotic Somatic Mutations in the Human Brain Expand the Threshold-Liability Model of Schizophrenia
por: Singh, Shiva M., et al.
Publicado: (2020) -
Towards Increasing the Clinical Relevance of In Silico Methods to Predict Pathogenic Missense Variants
por: Masica, David L., et al.
Publicado: (2016)